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INTRODUCTION
Mylabris, the dried body of the Chinese blister beetle (Myla-
bris phalerata Pallas), has been used as Chinese medicine for
over 2000 yr. Its active constituent, cantharidin (CA), has
anti-tumor properties and causes leukocytosis. However, it
has irritant effects on the urinary organs. Norcantharidin
(NCTD), the demethylated form of cantharidin (Fig. 1), is
easier to be synthesized and is relatively free from side effects.
NCTD inhibits the proliferation of some cancer cells (such as
HL60, K562, Bel-7402, MCF-7, Colo205, HT-29, SW480)
by interrupting DNA synthesis or upregulating of the CD95
receptor and CD95 ligand on the cell surface and has anti-
tumor activity against transplanted hepatoma in mouse model.
These findings suggest that NCTD is a potential antitumor
agent (1-3). However, the exact mechanism responsible for
the apoptotic effect is not thoroughly elucidated.
Apoptosis, or programmed cell death, is a genetically reg-
ulated, self-destructive cellular death process that is impor-
tant in development, tissue remodeling, immune regulation,
and many diseases (4-7). Cysteine-dependent aspartate-spe-
cific proteases (caspases) have been demonstrated to be cru-
cial mediators in apoptotic pathway. Caspases can be divid-
ed into two groups: initiator caspases (such as caspase-8 and
caspase-9) whose main function is to activate downstream
caspases, and executor caspases (such as caspase-3), which
mediate apoptosis by proteolysis of specific substrates includ-
ing inhibitor of caspase-activated DNase (ICAD) and anti-
apoptotic protein, Bcl-2 (8-12). Many Bcl-2 family proteins
reside the mitochondrial outer membrane. The balance bet-
ween Bax and Bcl-2 (or Bcl-xL) determines the fate of cells
in many apoptotic systems. Bcl-2 and Bcl-xL can be cleaved
by caspase-3 and cleavage of these proteins appears to inacti-
vate their survival function. In response to the death stimuli,
the mitochrondrial membranes are permeabilized, resulting
in the release of cytochrome c. In the cytosol, cytochrome c
activates apoptosis by binding and activating apoptotic pro-
tease activating factor-1 (Apaf-1)-caspase-9 complex, which
form an apoptosome acting as a processing/activation center
for the downstream caspase-3 (13-17). 
In the present study, we demonstrate that caspases activa-
tion participated in NCTD-induced apoptosis, and up-reg-
ulaton of Bax and down-regulation of Bcl-2 (or Bcl-xL) con-
tributed to the NCTD-induced A375-S2 cell apoptosis. 
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Norcantharidin Induces Human Melanoma A375-S2 Cell Apoptosis
through Mitochondrial and Caspase Pathways
Norcantharidin (NCTD) is the demethylated form of cantharidin, which is the active
substance of mylabris. To examine the pathway of NCTD-induced A375-S2 cell
death, 3-(4, 5-dimethylthiazol-2-yl)-2, 5-dipheyltetrazolium bromide (MTT) assay,
photomicroscopical observation, DNA agarose gel electrophoresis, caspase activi-
ty assay and Western blot analysis were carried out. A375-S2 cells treated with
NCTD exhibited several typical characteristics of apoptosis. The inhibitory effect of
NCTD on human melanoma, A375-S2 cells, was partially reversed by the inhibitors
of pan-caspase, caspase-3 and caspase-9. The activities of caspase-3 and -9 were
significantly increased after treatment with NCTD at different time. The expression
of inhibitor of caspase-activated DNase was decreased in a time-dependent man-
ner, simultaneously, the ratio of Bcl-2/Bax or Bcl-xL/Bax was decreased and the
expression ratio of proteins could be reversed by caspase-3 inhibitor. The expres-
sion of cytochrome c in cytosol was increased after NCTD treatment and caspase-
3 inhibitor had no significant effect on the up-regulation of cytochrom c. These
results suggest that NCTD induced A375-S2 cell apoptosis and the activation of
caspase and mitochondrial pathway were involved in the process of NCTD-induced
A375-S2 cell apoptosis.
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MATERIALS AND METHODS
Chemical reagents 
NCTD of analytical grade purity was from the Ju-nan Phar-
maceutical Works (Junan, China) and dissolved in RPMI-
1640 (HyClone, U.S.A.). Caspase-8 inhibitor (z-IETD-fmk)
was from Enzyme Systems (CA, U.S.A.). Caspase-3 inhibitor
(z-DEVD-fmk) and pan-caspase inhibitor (z-VAD-fmk) were
from Calbiochem (CA, U.S.A.). Caspase-9 inhibitor (Ac-
LEHD-CHO), rabbit polyclonal antibodies against ICAD,
cytochrome c, Bax and Bcl-xL, mouse polyclonal antibodies
against Bcl-2, horseradish peroxidase-conjugated secondary
antibody (goat-anti-rabbit or goat-anti-mouse) were from Santa
Cruz Biotechnology (Santa Cruz, CA). Caspase-3, -8 and -9
Apoptosis Detection Kits were from Santa Cruz Biotech-
nology (Santa Cruz, CA).
Cell culture
A375-S2, melanoma cells, were obtained from American
Type Culture Collection (ATCC, #CRL, 1872, MD, U.S.A.)
and were cultured in RPMI-1640 medium (HyClone, U.S.A.)
supplemented with 10% heat inactivated (56℃, 30 min)
fetal calf serum (Beijing Yuanheng Shengma Research Insti-
tution of Biotechnology, Beijing, China), 2 M L-glutamin
(GIBCO, U.S.A.), 100 kU/L penicillin and 100 g/L strepto-
mycin (GIBCO, U.S.A.) at 37℃in 5% CO2.
Cell growth inhibition test 
A375-S2 cells (1.0×108 cells/L) seeded in 96-well plate
(NUNKTM, Roskilde, Denmark) were cultured for 24 hr, then
various concentrations of NCTD (60-480  M) were added
and cultured for 12, 24, 36, 48 hr further. MTT (thiazolyl
blue, Sigma, MO, U.S.A.) test were carried out to detect cell
growth using an enzyme-linked immunosorbent assay plate
reader (TECAN, Austria) (18). After preincubation with
given concentrations of pan-caspase inhibitor (z-VAD-fmk),
caspase-8 inhibitor (z-IETD-fmk), caspase-9 inhibitor (Ac-
LEHD-CHO), caspase-3 inhibitor (z-DEVD-fmk) for 2 hr,
60  M NCTD were added and cultured for further 24 hr.
Growth inhibition was evaluated by MTT method. The per-
centage of cell growth inhibition was calculated as follows:
Relative viability (%)={1-[A492 (control)-A492 (NCTD)]}/
A492 (control)×100
Nuclear damage observed by Hoechst 33258 staining 
Apoptotic nuclear morphology was assessed using Hoechst
33258 (Sigma, U.S.A.) as previously described (19). A375-
S2 cells, containing adherent and floating, were collected by
centrifugation at 1,000 g for 5 min, washed two times with
PBS. The cells were fixed with 3.7% paraformaldelyde at
room temperature for 2 hr, then washed and stained with
Hoechst 33258 167  M at 37℃ for 30 min. At the end of
incubation, the cells were washed and resuspended in PBS
for observation of nuclear morphology using fluorescence
microscope (Nikon, Osaka, Japan).
Lactate dehydrogenase (LDH) activity-based cytotoxicity
assays (20, 21)
The cells were cultured with NCTD for 12, 24 or 36 hr.
Floating dead cells were collected from culture medium by
centrifugation (240 g for 10 min at 4℃), and the lactate
dehydrogenase (LDH) content from the pellets lysed in 1%
NP-40 for 15 min was used as an index of apoptotic cell death
(LDHp). The released LDH in the culture medium (extra-
cellular LDH or LDHe) was used as an index of necrotic cell
death. The adherent and viable cells were lysed in 1% NP40
for 15 min to release LDH (intracellular LDH or LDHi).
Then the substrate reaction buffer of LDH (L (+)-lactic acid
0.5 mM, indonitrotetrazolium 0.66 mM, phenazine metho-
sulfate 0.28 mM,  -nicotinamide adenine dinucleotide 1.3
mM in pH 8.2 Tris-HCl) was added. The OD value at 492
nm of reaction for 1 and 5 min were assayed and LDH activi-
ties were determined by the average difference between 1
min and 5 min. The percentage of apoptotic and necrotic
cell death was calculated as follows:
% apoptosis=LDHp/(LDHp+LDHe+LDHi)×100
% necrosis=LDHe/(LDHp+LDHe+LDHi)×100
Determination of DNA fragmentation by agarose gel
electrophoresis 
DNA extraction and electrophoresis were performed as
described previously (22). In brief, A375-S2 cells, contain-
ing adherent and floating, were collected by centrifugation
at 1,000 g for 5 min. The cell pellet was suspended in cell
lysis buffer [Tris-HCl 10 mM (pH 7.4), EDTA 10 mM (pH
8.0), Triton-100 0.5%) and kept at 4℃for 10 min. The lysate
was centrifuged at 25,000 g for 20 min. The supernatant was
incubated with RNase A 40  g/L (Sigma) at 37℃ for 1 hr,
then incubated with proteinase K 40  g/L (Merck) at 37℃for
Fig. 1. Structures of cantharidin (CA) and norcantharidin (NCTD).
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1 hr. The supernatant was mixed with NaCl 0.5 M and 50%
2-propanol at -20℃overnight, then centrifuged at 25,000 g
for 15 min. After drying, DNA was dissolved in TE buffer
[Tris-HCl 10 mM (pH 7.4), EDTA 1 mM (pH 8.0)] and sep-
arated by 2% agarose gel electrophoresis at 100 V for 1 hr.
Assay of caspase activities
A375-S2 cells were treated with or without NCTD. Anal-
ysis of caspase-3, caspase-8 and caspase-9 activities was per-
formed using Caspase Apoptosis Detection Kit (Santa Cruz,
CA, U.S.A.) according to the manufacturer’s instruction. In
brief, harvested cells at various time points were washed with
PBS two times and centrifuged at 150 gfor 5 min. The super-
natant was aspirated off and 100  L cell lysis buffer (provid-
ed) was added to an Eppendorf centrifuge at 500  L per 1×
106 cells. Cells in the lysis buffer were incubated on ice for
10 min. Reaction buffer containing 10  L DTT, 10  L of
DEVD-AFC, IEVD-AFC or LEHD-AFC substrates and 380
L H2O was added to each aliquot of cell lysate. The reaction
mixtures were incubated at 37℃ for 1 hr. The fluorescence
of the cleaved substrates was determined with a spectrofluo-
rometer set at 400 nm excitation wavelength and at 505 nm
emission wavelength. The unit of enzyme activity corresponds
to the activity that cleaves the respective substrate in 1 min/
mg protein at 37℃.
Western blot analysis  
A375-S2 cells were treated with 60  M NCTD for 0, 12,
24, 36 hr. Both adherent and floating cells were collected
and frozen at -80℃. Western blot analysis was performed as
previously described (23) with some modification. Briefly,
A375-S2 cells were lysed for 1 hr on ice in lysis buffer [50
mM HEPES (pH 7.4), 1% Triton X-100, 2 mM sodium
orthovanadate, 100 mM sodium fluoride, 1 mM EDTA, 1
mM phenylmethanesulfonyl fluoride (PMSF)], supplement-
ed with proteinase inhibitors: 100  g/mL aprotinin, 10  g/
mL leupeptin, and 100  g/mL pepstatin. Protein concen-
tration was determined by the Bio-Rad DC protein assay
(Bio-Rad Laboratories, Hercules, CA). The lysate was cen-
trifuged at 16,000 g at 4℃ for 10 min. Equivalent amounts
of protein lysates were mixted in 2×loading buffer [50 mM
Tris-HCl (pH 6.8), 2% SDS, 10% 2-mercaptoethanol, 10%
glycerol, and 0.002% bromphenol blue], heated at 100℃
for 5 min, and then analyzed by electrophoresis in 12% SDS
polyacrylamide gel and blotted onto nitrocellulose membrane
(Amersham Biosciences, U.K.). After blocked with Tween
20-Tris-buffer saline [50 mM Tris-HCl (pH 7.5), 150 mM
NaCl, and 0.02% Tween 20] containing 5% nonfat milk at
room temperature with the primary antibodies at 1:500 dilu-
tion in blotting buffer. After washed 3 times for 10 min each
in Tris-buffered saline, the membrane was incubated with a
diluted horseradish peroxidase-labeled secondary antibody
(1:500) in blotting buffer at room temperature for 1 hr. After
3 more washes, proteins were detected by chemilumines-
cence, according to the manufacturer’s instructions (Bio-Rad
Laboratories, Hercules, CA).
Statistical Analysis 
All results were confirmed in at least three separate exper-
iments. Data are expressed as mean±SD. Data of the repre-
sentative were analyzed for statistical significance by Stu-
dent’s t test. p-value of less than 0.05 was considered statis-
tically significant.
Fig. 2. Cytotoxic effects of NCTD on A375-S2 cell. Cells were treated with various doses of NCTD for 24 hr (A) or 60  M NCTD for various
time periods (B). The relative viability of cells was determined by MTT assay. Results are represented as mean±SD, n=3.
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RESULTS
Cytotoxicity of NCTD on A375-S2 cells by MTT assay 
NCTD 15 to 240  M exerted potent inhibitory effect on
A375-S2 cell growth. By 24 hr after NCTD 60  M treat-
ment, cell death rate reached to almost 50% (Fig. 2).
NCTD-induced morphological changes and DNA 
fragmentation of A375-S2 cells 
In control group, A375-S2 cells were round in shape and
stained homogeneously. After 24 hr treatment with NCTD,
blebbing nuclei and granular apoptotic bodies appeared (Fig.
3, arrows). 
DNA fragmentation as a hallmark of apoptosis was observed
Fig. 3. Cellular morphology of NCTD-treated A375-S2 cells. Cells
were cultured without NCTD (control) or with 60  M NCTD for 24
hr. Morphological change were observed by fluorescent micro-
scopy (×200). Arrows indicate condensed nuclei.
Control NCTD
Fig. 4. NCTD-induced DNA fragmentation in A375-S2 cells. The
cells were cultured in the presence of NCTD 60  M for 0, 6, 12,
24 and 36 hr. Genomic DNA was extracted and analyzed via elec-
trophoresis on 2% agarose gels. Lane M: DNA molecular markers.
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Fig. 5. Ratio of apoptosis and necrosis in A375-S2 cells. Cells were
treated with 0, 15, 30, 60,120, 240  M NCTD for 24 hr. The ratios
of LDH released from floating dead cells and the culture medium
were used to distinguish the proportion of apoptotic and necrotic
cells. Results are represented as mean±SD, n=5.
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Fig. 6. Effect of caspase inhibitors on NCTD-induced A375-S2 cells
apoptosis. The cells were cultured in the presence or absence of
caspase inhibitors. Two hours prior to the addition of 60  M NCTD,
pan-caspase inhibitor (z-VAD-fmk, 40  M), caspase-3 inhibitor
(z-DEVD-fmk, 20  M), caspase-8 inhibitor (z-IETD-fmk, 20  M),
caspase-9 inhibitor (Ac-LEHD-CHO, 20  M) were added, then
further incubated for 24 hr. A: NCTD-treated group; B: NCTD- and
z-VAD-fmk-treated group; C: NCTD- and z-DEVD-fmk-treated
group; D: NCTD- and z-IETD-fmk-treated group; E: NCTD- and
Ac-LEHD-CHO-treated group; F: z-VAD-fmk-treated group; G: z-
DEVD-fmk-treated group; H: z-IETD-fmk-treated group; I: z-LEHD-
fmk-treated group. Results are represented as mean±SD, n=3.
*p<0.05, **p<0.01 vs. group A.
30.44
69.02
** **
**
61.04
37.67
48.50
85.27
94.55
97.52 94.84564 W.-w. An, M.-w. Wang, S.-i. Tashiro, et al.
in NCTD-treated A375-S2 cells (Fig. 4). 
Apoptosis of A375-S2 cell death identified by LDH
released assay
The ratio of apoptotic A375-S2 cells increased from 4.6%
at 0  M NCTD to 38.5% at 240  M NCTD, however, that
of necrotic cells were still negligible (Fig. 5). 
Effect of caspases on NCTD-induced cytotoxicity in
A375-S2 cells  
A375-S2 cells were treated with 60  M NCTD for 24 hr
in the absence or presence of various caspase inhibitors: pan-
caspase inhibitor (z-VAD-fmk, 40  M), caspase-3 inhibitor
(z-DEVD-fmk, 20  M), caspase-8 inhibitor (z-IETD-fmk,
20  M), caspase-9 inhibitor (Ac-LEHD-CHO, 20  M). Z-
VAD-fmk, z-DEVD-fmk and Ac-LEHD-CHO partially
blocked NCTD-induced A375-S2 cell apoptosis. Inhibitory
ratio was 30.98%, 38.96%, and 51.50%, respectively. How-
ever, caspase-8 inhibitor did not affect the death ratio (Fig. 6).
Caspase-3 activity was significantly enhanced after the cells
were treated with NCTD 60  M at different time points,
however, caspase-9 activity increased moderately and increase
of caspase-8 activity was almost negligible (Fig. 7).
The ICAD protein degradation was significant after 24 hr
incubation with NCTD (Fig. 8), and this change was blocked
by caspase-3 inhibitor. 
Involvement of mitochondrial proteins in NCTD-induced
A375-S2 cell apoptosis 
After incubation with NCTD, protein expression ratio of
Bcl-xL/Bax and Bcl-2/Bax was down-regulated, and this change
was blocked by caspase-3 inhibitor. At the same time, the
protein of cytchrome c was increased in cytosol and caspase-
3 inhibitor had no influence on the increase (Fig. 9).
DISCUSSION
The present study showed that NCTD inhibited A375-
S2 cell growth in a time- and dose-dependent manner. At
the same time we demonstrated that NCTD induced apop-
tosis in A375-S2 cells and the apoptosis was possibly associ-
ated with caspases. Caspases are a family of cysteine proteas-
es that are activated during the apoptotic processes. Death
receptors such as Fas induce caspase-8 activation via Fas-asso-
ciated death domain protein (FADD). It was reported that
in human colorectal carcinoma cell lines NCTD induced
apoptosis by activation of caspase-8, which was prevented by
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Fig. 7. Effects of NCTD on the activation of caspase-3, -8, -9 in
A375-S2 cells. Cells were treated with NCTD 60  M for 0, 8, 18
and 28 hr. Caspase-3, caspase-8 and caspase-9 activities was
performed using Caspase Apoptosis Detection Kit according to
the manufacturer’s instruction. Results are represented as mean
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Fig. 8. Effects of NCTD on ICAD expression in the absence or
presence of caspase-3 inhibitor (z-DEVD-fmk). A375-S2 cells were
treated with 60  M NCTD only for 0, 12, 24 and 36 hr. Two hours
prior to the addition of NCTD, caspase-3 inhibitor (z-DEVD-fmk,
20  M) were added, then further incubated for 36 hr. Cell lysates
were separated by 12% SDS-PAGE, and ICAD was detected by
Western blot analysis.
ICAD
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NCTD NCTD+z-DEVD-fmk
45 kD
Fig. 9. Effects of NCTD on Bcl-2, Bcl-xL and Bax expression in the
absence or presence of caspase-3 inhibitor (z-DEVD-fmk). A375-
S2 cells were treated with 60  M NCTD only for 0, 12, 24 and 36
hr. Two hours prior to the addition of NCTD, caspase-3 inhibitor
(z-DEVD-fmk, 20  M) were added, then further incubated for 36
hr. Cell lysates were separated by 12% SDS-PAGE, and Bcl-2,
Bcl-xL and Bax proteins were detected by Western blot analysis.
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the pan-caspase inhibitor z-VAD-fmk and caspase-8 inhibitor
z-IETD-fmk (1), but the inhibition pathways of NCTD-
induced apoptosis remain unclear. Morphological observa-
tion, DNA fragmentation and LDH activity assay suggest-
ed that NCTD induced A375-S2 cell death involved a mecha-
nism of apoptosis. In the present study, NCTD-induced
A375-S2 cell death was blocked by pan-caspase inhibitor,
indicating that caspase family play a role in the apoptotic
process. Caspase-3, and caspase-9 inhibitor (z-DEVD-fmk,
Ac-LEHD-CHO, respectively) partially blocked NCTD-
induced A375-S2 cell apoptosis, whereas caspase-8 inhibitor
(z-IETD-fmk) had no effect on A375-S2 cell death induced
by NCTD, indicating that post-mitochondrial caspase-9, but
not upper stream caspase-8, activated this apoptotic process. 
Chemotherapeutic agents and UV irradiation cause release
of mitochondrial cytochrome c, which binds to Apaf-1, and
this complex mediates recruitment of procaspase-9 and acti-
vates caspase-3. ICAD is expressed as two isoforms, ICAD-
L/DFF45 and ICAD-S/DFF35. Once ICAD/DFF45 is cleaved
by caspase-3 or caspase-7, CAD is released to the nucleus
and induces DNA fragmentation, resulting in the morpho-
logical and biochemical features of apoptosis (9, 10, 20, 24,
25). To further confirm the participation of different caspas-
es in the cell death, we examined the activities of caspase-3,
-8, and -9 and the protein expression of cytochrome c and
the substrate for caspase-3, ICAD. The activities of caspase-
9 and caspase-3 were up-regulated at 8 and 18 hr, respec-
tively, but capase-8 activity just showed slight change after
28 hr treatment. The protein expression of cytochrome c was
up-regulated and the protein expression of ICAD was sig-
nificantly down-regulated. Based on these results, we con-
cluded that caspase-9-activated apoptotic pathway played a
role in the apoptotic pathway of NCTD-treated A375-S2
cells. On the other hand, since NCTD-induced A375-S2 cell
apoptosis was only partially reduced by caspase inhibitors, it
is possible that other apoptotic pathways might also partic-
ipate in this process.
Several pro-apoptotic proteins, such as Bax, Bak, and Bid,
translocate to the mitochondrial membrane, and this local-
ization is associated with their pro-apoptotic activities. It
has been reported that Bcl-2 could exert its action through
heterodimerization with Bax. Meanwhile, Bcl-2 and Bcl-xL
are cleaved by caspase-3 and are converted to pro-apoptotic
proteins similar to Bax. Therefore, the ratio between Bcl-2
and Bax or Bcl-xL and Bax is a decisive factor to activate cell
death (9, 15, 26-29). A375-S2 cells treated with NCTD
exhibited the elevated ratio between pro-apoptotic Bax and
anti-apoptotic Bcl-2 or Bcl-xL. The oligomerization of Bax
in the mitochondrial membrane has been shown to induce
cytochrome c release, meanwhile pro-apoptotic Bcl-2 cleav-
age product was reported to localize on mitochondrial mem-
brane and caused release of cytochrome c (9, 30, 31). In our
study, the protein expression of cytochrome c was markedly
up-regulated followed by the changes of Bcl-2/Bax and Bcl-
xL/Bax ratios at 24 hr in A375-S2 cell treated by NCTD. At
the same time, the change of Bcl-2/Bax or Bcl-xL/Bax ratio
was blocked by caspase-3 inhibitor, and caspase-3 inhibitor
had slight effect on the expression of cytochrome c, indicat-
ing a potential positive feedback loop that ensures the death
of the cell. These results suggested that the mitochondrial
pathway of cell death, including Bcl-2 family and cytochrome
c, might be involved in A375-S2 cell death and orchestrate
the caspase cascades.
In conclusion, NCTD inhibited A375-S2 cell growth and
caspase-9, caspase-3 activation was involved in the apoptotic
progression. Simultaneously mitochondrial pathway, includ-
ing cytochrome c, Bax and Bcl-2 (or Bcl-xL), contributed to
the NCTD-induced A375-S2 cell apoptosis. More detailed
mechanism of NCTD-induced A375-S2 cell apoptosis remains
to be elucidated.
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